Pharmacy Report Archives - Page 50 of 150 - Becker's Hospital Review

Top 10 issues in pharmacies | FDA updates China-made syringes probe | The 3rd generation of weight loss drugs | Iowa RN pleads not guilty to overdosing patients | 9 Medicaid programs that cover Wegovy

Becker's Pharmacy Report is a top resource for healthcare leaders and one of our most-read newsletters. If this is in your “promotions” folder, please drag it to your regular inbox so you can receive future updates. March 20, 2024 BHR…

Henry Ford's central pharmacy eyes $30M in savings | Zepbound eclipses Wegovy in 1st-time scripts | GSK, Duke U halt RSV shot trial | Top-paying nonphysician jobs | Most, least stressed states

Becker's Pharmacy Report is a top resource for healthcare leaders and one of our most-read newsletters. If this is in your “promotions” folder, please drag it to your regular inbox so you can receive future updates. March 19, 2024 BHR…

CHS, Mark Cuban's partnership: What to know | Trinity pharmacy to temporarily close | ASHP: Pharmacy residencies in growth mode | Walgreens lays off 600+ workers | 1st MASH therapy approved

Becker's Pharmacy Report is a top resource for healthcare leaders and one of our most-read newsletters. If this is in your “promotions” folder, please drag it to your regular inbox so you can receive future updates. March 18, 2024 BHR…

9 new drug shortages | Halt dispensing EUA-labeled Paxlovid: FDA | CAR-T drug safety debate set for tomorrow | 9 Ozempic updates | 10 systems seeking pharmacy leaders

Becker's Pharmacy Report is a top resource for healthcare leaders and one of our most-read newsletters. If this is in your “promotions” folder, please drag it to your regular inbox so you can receive future updates. March 14, 2024 BHR…

Appeals court sides with 340B contract pharmacies | Amazon to deliver Zepbound | Weight loss drug efficacy, compared | Presbyterian CEO to retire | Drug shortages group seeks leader

Becker's Pharmacy Report is a top resource for healthcare leaders and one of our most-read newsletters. If this is in your “promotions” folder, please drag it to your regular inbox so you can receive future updates. March 13, 2024 BHR…

340B hospitals saved $30B in 5 years | Weight loss drugs bolster transplants | Resistance grows in common HIV drug | Mark Cuban's $141K oversight | 79 top hospitals for patients: Healthgrades

Becker's Pharmacy Report is a top resource for healthcare leaders and one of our most-read newsletters. If this is in your “promotions” folder, please drag it to your regular inbox so you can receive future updates. March 12, 2024 BHR…

Syphilis drug shortage persists | Wegovy secures 2nd indication | Mark Cuban's startup: 2 years later | 3 top safety issues in pharmacies: ECRI | Pharmacists address second victim syndrome

Becker's Pharmacy Report is a top resource for healthcare leaders and one of our most-read newsletters. If this is in your “promotions” folder, please drag it to your regular inbox so you can receive future updates. March 11, 2024 BHR…

Mark Cuban's drug co. nets 1st system partner | 10 drugs poised to be top-sellers | Lab finds carcinogens in acne products | 10 systems seeking pharmacy leaders | The 'right time' for retirement

March 7, 2024 BHR Newsletter 1. 10 drugs poised to be best-sellers in 2024 Full story 2. Mark Cuban's drug company partners with 1st health system Full story 3. Best, worst states to be rich Full story 4. 90 patients…

Mark Cuban to start making 2 drugs this week | Man OK after 217 COVID shots | 8 Ozempic updates | US launches Rx pricing task force | RSV vaccine: 5 safety notes

March 6, 2024 BHR Newsletter 1. 8 Ozempic updates Full story 2. Mark Cuban's pharma company to start manufacturing 2 drugs this week Full story 3. Man got 217 COVID shots — here's what happened Full story 4. Hospitals are…

Ozempic cuts risk of kidney problems | Hospital pharmacies request paused audits amid Change fallout | Systems magnify weight loss programs | Pharmacy CEO sentenced in $40M fraud case

March 5, 2024 BHR Newsletter 1. Health systems double down on weight loss programs Full story 2. Ozempic cuts risk of kidney problems in diabetes patients: New data Full story 3. Drugmakers send CMS counteroffers in fair price negotiations Full…